anti- CXCR2 antibody

Este producto es parte de CXCR - C-X-C motif chemokine receptor
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
anti- CXCR2 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab02100
tested applications
ELISA, WB, IF, IP

Description

Receptor for interleukin-8 which is a powerful neutrophil chemotactic factor. Binding of IL-8 to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. Binds to IL-8 with high affinity. Also binds with high affinity to CXCL3, GRO/MGSA and NAP-2.

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

CategoryPrimary Antibodies
Immunogen Targetinterleukin 8 receptor, beta
HostRabbit
Reactivityhuman
Recommended DilutionWB: 1:500-1:2000; IP: 1:200-1:1000; IF: 1:20-1:200
Clonalitypolyclonal
ConjugationUnconjugated
IsotypeIgG
Observed MW45-50 kDa
Purity≥95% as determined by SDS-PAGE
PurificationImmunogen affinity purified
Size 1100µg
Formliquid
Tested ApplicationsELISA, WB, IF, IP
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt IDP25025
Gene ID3579
AliasCXCR2,C-X-C motif chemokine receptor 2,CD182,IL8R2,IL8RA,IL8RB,CMKAR2,WHIMS2,CDw128b,KC receptor,CXC-R2,high affinity interleukin-8 receptor B,CD128,Gpcr16
BackgroundAntibody anti-CXCR2
StatusRUO
NoteThis product is for research use only.

Descripción

CXCR2 is a G protein-coupled receptor that binds IL-8 and other CXC chemokines like Groα, Groβ, and NAP-2. It is mainly expressed on neutrophils, endothelial cells, and monocytes, mediating chemotaxis, neutrophil activation, and cytokine release during inflammation. CXCR2 signaling activates pathways such as PI3K, MAPK, and NF-κB, while its rapid desensitization and internalization regulate signal duration. CXCR2 is critical for immune surveillance and inflammation but also contributes to diseases like COPD, asthma, and rheumatoid arthritis due to excessive neutrophil infiltration. In cancer, CXCR2 promotes tumor progression, angiogenesis, and metastasis by recruiting myeloid-derived suppressor cells (MDSCs) and endothelial cells to the tumor microenvironment, enhancing immunosuppression and vascularization. CXCR2 inhibition reduces tumor growth and inflammation, highlighting its therapeutic potential. It also regulates leukocyte trafficking and tissue repair but contributes to pathologies like cystic fibrosis and inflammatory bowel disease (IBD) when dysregulated. Overall, CXCR2 is key for immune cell recruitment and inflammation, balancing host defense with disease progression.

Related Products

EH4313

Human CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto
EM1613

Mouse CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto
ER1623

Rat CXCR2(C-X-C chemokine receptor type 2) ELISA Kit

Ver Producto